Definitive Contract 75F40121C00188
Award Date
9/29/21
Potential Completion Date
3/31/25
Potential Value
$750K
Federal Agency
Food and Drug Administration
Awardee
University Of Florida
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
10
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, identified as HHSF223201610099C, was made by the Food and Drug Administration (FDA) to the University of Florida (UF) Division of Sponsored Research. The contract, valued at $764,975.37, is for a Pharmacokinetic Comparison of Locally Acting Orally Inhaled Drug Products. This work falls under the FDA's Broad Agency Announcement (BAA) program for this research area. The contract is a definitive, cost-no-fee contract, with a performance period ending on March 22,...
This is a $500,000 firm-fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to the University of Florida (UF) Division of Sponsored Research for a pharmacokinetic comparison study of locally acting orally inhaled drug products. The contract does not have a set-aside designation, indicating UF competed for and was awarded the contract based on its extensive research capabilities. UF is a major research institution that provides a wide range of goods and services to...
The U.S. Food and Drug Administration (FDA) awarded a $296,477.00 definitive contract to the University of Florida (UF) Division of Sponsored Research for research related to "REAL-TIME RISK STRATIFICATION FOR HYPO- OR HYPERGLYCEMIA TO ENHANCE GLUCOSE MANAGEMENT OUTCOMES IN HOSPITALS." The contract, which is not set-aside, has a completion date of September 29, 2017. UF, a major research institution, has an extensive portfolio of federal contract and grant awards across various...
The Department of Health and Human Services Food and Drug Administration awarded a $921,732.78 firm fixed-price definitive contract to the University of Florida's Division of Sponsored Research to conduct research on the "Systematic Evaluation of the Ex-Throat Plume Properties of MDI Formulations." The contract does not have any set-aside designation. As a public land-grant research university, the University of Florida has extensive experience providing research, development, testing,...
The U.S. Food and Drug Administration (FDA) awarded a 4-month, $24,480 firm-fixed-price (FFP) purchase order to the University of Florida (UF) Division of Sponsored Research to provide training courses for the FDA's Center for Drug Evaluation and Research (CDER), Office of Clinical Pharmacology (OCP) to support its Advanced Model-Informed Drug Development (MIDD) program. This purchase order is not associated with a larger contract vehicle and does not have a set-aside designation. As a major...
This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency within the Department of Health and Human Services, to the University of Florida College of Medicine Division for a collaborative malignant hyperthermia human genetics study. The contract has a ceiling value of $9,457.40 and a completion date of June 15, 2023. No set-aside was used for this award. The University of Florida is a top public research...
This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) Strategic Acquisition Center in Frederick, Maryland to the University of Florida (UF) Division of Sponsored Research. The contract, valued at $50,000.00, is for the development of prototypes. The contract has no set-aside designation, indicating UF was able to compete for and win the award based on its extensive research and development capabilities. UF is a major research institution...
This is a $23,648 firm-fixed-price purchase order contract awarded to the University of Florida's Division of Sponsored Research by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health. The contract has a period of performance through June 30, 2026. The University of Florida is a major public research university and an 1862 land-grant institution with extensive experience in executing federal research contracts and grants across a wide range of...
This is a definitive, firm fixed-price contract awarded by the Veterans Integrated Service Network 6 (VISN 6) of the Department of Veterans Affairs to the University of Florida (UF) Division of Sponsored Research, with a ceiling value of $134,400.00. The contract is for "COST PER TEST" and does not have a set-aside designation. UF has a significant research portfolio, including federal contracts and grants from agencies such as the Department of Defense, NASA, and National Institutes...
This is a definitive cost-no-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the University of Florida's Institute of Food and Agricultural Sciences. The $4,489,146.36 contract is for the development of a "multipotential mitigation agent for gastrointestinal syndrome" under the FGP-P program. The contract has a period of performance that runs through March 8, 2022, and does not have a set-aside designation. The University...